Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Northside Hospital, Inc.
Children's Oncology Group
Children's Oncology Group
University of Chicago
Children's Oncology Group
Children's Cancer Group, China
University of Chicago
City of Hope Medical Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Children's Oncology Group
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Novartis
Dana-Farber Cancer Institute
Stanford University
University of Chicago
Ruijin Hospital
Children's Oncology Group
Institute of Hematology & Blood Diseases Hospital, China
Goethe University
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Sanofi
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Therapeutic Advances in Childhood Leukemia Consortium
Dana-Farber Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
Amgen
Janssen Research & Development, LLC